Essex Bio-Technology Limited

HKEX:1061.HK

2.64 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q22009 Q2
Revenue 811.63807.197899.359661.886655.825900.285737.374654.276323.835697.762581.716615.18561.278461.953437.637411.715363.948340.591313.419286.968231.332181.897165.15000037.57129.406
Cost of Revenue 87.01878.36688.89759.20169.181127.213114.68115.15969.125133.174112.95100.933101.98381.91180.07783.9468.69667.6856.73965.59941.44421.23514.87900003.1942.953
Gross Profit 724.612728.831810.462602.685586.644773.073622.694539.117254.71564.588468.766514.247459.295380.042357.56327.775295.252272.912256.68221.369189.888160.662150.271000034.37726.453
Gross Profit Ratio 0.8930.9030.9010.9110.8950.8590.8440.8240.7870.8090.8060.8360.8180.8230.8170.7960.8110.8010.8190.7710.8210.8830.9100000.9150.9
Reseach & Development Expenses 14.88318.89520.2511.90211.60612.44311.085.6172.962.2911.11713.0765.3673.0763.3552.7182.9346.7335.331.1495.8842.1474.414000000
General & Administrative Expenses 102.879115.69101.27776.41379.56484.69569.06165.86345.74947.50534.21944.00524.90423.04817.35727.27820.68126.93724.22120.52421.84414.6810.89400003.6463.382
Selling & Marketing Expenses 450.305491.333520.663394.405363.808458.674377.28313.093163.537332.136300.684336.962312.757267.463247.835207.853202.686183.452168.657141.52129.846109.044102.958000022.58616.829
SG&A 553.184582.005601.69462.828430.023533.452435.646370.672207.792375.755334.135380.967337.661290.511265.192235.131223.367210.389192.878162.044151.69123.724113.852000026.23220.211
Other Expenses 00000000000000000000000000000
Operating Expenses 568.067600.899621.94474.73441.629545.895446.726376.289210.752378.045335.252359.901336.513274.197263.476232.083222.468205.864191.299161.116150.785122.291113.752000026.06720.185
Operating Income 156.545127.932188.522127.955145.015227.178175.968162.82843.958186.543133.514152.896122.782105.50494.08491.91872.78465.14867.28160.25339.10338.37136.51900008.316.268
Operating Income Ratio 0.1930.1580.210.1930.2210.2520.2390.2490.1360.2670.230.2490.2190.2280.2150.2230.20.1910.2150.210.1690.2110.22100000.2210.213
Total Other Income Expenses Net 42.78513.22816.333-4.02217.686-15.7957.10630.23713.83215.44216.26631.2080.00719.145-0.921-3.083-0.22410.638-3.0570.216-1.742.789-1.0370000-0.004-0.007
Income Before Tax 199.33142.222205.43497.836162.701211.383183.074193.06557.79201.985149.78151.413121.641105.59991.44789.67872.5666.42764.22458.39237.36337.5835.48200008.3066.261
Income Before Tax Ratio 0.2460.1760.2280.1480.2480.2350.2480.2950.1780.2890.2570.2460.2170.2290.2090.2180.1990.1950.2050.2030.1620.2070.21500000.2210.213
Income Tax Expense 39.9435.71135.04411.46123.4727.60120.88823.3278.60229.05820.20519.23722.72515.4214.32715.38110.57313.17412.58213.7076.7759.5568.60900001.4871.15
Net Income 157.44105.449169.81186.18139.231183.782162.186169.73849.188172.927129.575132.17698.91690.17977.1274.29761.98753.25351.64244.68530.58828.02426.87300006.8192.897
Net Income Ratio 0.1940.1310.1890.130.2120.2040.220.2590.1520.2480.2230.2150.1760.1950.1760.180.170.1560.1650.1560.1320.1540.16300000.1810.099
EPS 0.280.190.30.150.240.320.280.290.0850.30.220.220.170.160.140.130.110.0930.0920.080.0550.050.04800000.010.005
EPS Diluted 0.270.180.280.150.230.310.270.280.0850.290.210.220.160.160.140.130.110.0930.0920.080.0550.050.04800000.010.005
EBITDA 200.279172.48245.897125.888187.648231.6204.653205.32374.18218.926167.222162.437132.332116.87100.48999.27578.19770.13672.33465.32243.8940.16237.18400008.316.268
EBITDA Ratio 0.2470.1940.2440.2250.2520.2710.2610.2710.1760.2880.2520.2640.2360.2530.230.2410.2150.2060.2310.2280.190.2210.22500000.2210.213